Publications by authors named "R S Wilder"
Factors associated with exclusive breastfeeding for the first six months among caregivers of children under five years in northern Ghana: A cross-sectional study.
PLOS Glob Public Health
November 2024
Despite consistent evidence highlighting the benefits of exclusive breastfeeding (EBF) for the first six months, EBF duration sometimes falls short of six months or exceeds it. This research seeks to explore factors influencing the practice of optimal duration of EBF and identify factors associated with suboptimal EBF durations. A cross-sectional survey was conducted in 16 districts across four Northern regions of Ghana with 2000 caregivers of children under five years old.
View Article and Find Full Text PDFPediatric pain physician workforce: an assessment of supply and demand.
Front Pain Res (Lausanne)
October 2024
Introduction: Many youth with pain lack access to pediatric pain expertise. There is a critical shortage of pediatric pain physicians, due partly to a paucity of training programs in Pediatric Pain Medicine. Pain fellowships are Anesthesiology-based and there is no pathway to fellowship training or Pain Medicine board certification for pediatricians.
View Article and Find Full Text PDFArticle Synopsis
- A study was conducted to evaluate the effectiveness of montelukast versus a placebo in helping outpatients with mild to moderate COVID-19 recover from symptoms more quickly.
- The trial included 1,250 participants over 30 years old with confirmed COVID-19 symptoms for less than a week, who were randomly assigned to receive either montelukast or a placebo for 14 days.
- Results showed no significant difference in recovery time between the montelukast and placebo groups, with both groups having a median recovery time of 10 days and no reported deaths.
Article Synopsis
- The American Academy of Pediatrics released their first clinical practice guideline to help healthcare providers safely prescribe opioids for acute pain in children and adolescents, focusing on minimizing risks such as opioid use disorder and overdose.
- The guideline also highlights disparities in pain management for Black, Hispanic, and American Indian/Alaska Native youth, advocating for fair treatment across all demographics, regardless of language, socioeconomic status, or geographic location.
- It emphasizes a multimodal approach to pain management, recommending nonpharmacologic therapies and nonopioid medications, with strict guidelines for opioid prescriptions, including avoiding certain medications for specific age groups and starting with low doses and short supply durations.
Article Synopsis
- - The study aimed to determine the effectiveness of montelukast, a medication, versus a placebo in helping outpatients with mild to moderate COVID-19 recover from their symptoms more quickly.
- - Conducted as part of the ACTIV-6 trial, 1250 participants aged 30 and older were enrolled from across 104 U.S. sites, receiving either montelukast or a placebo for 14 days.
- - Results showed no significant difference in recovery times between those taking montelukast and those taking the placebo, with both groups having a median recovery time of 10 days and minimal hospitalizations or adverse events reported.